Medical Marijuana Inc. (OTC:MJNA).
The move comes on the heels of Kannnaway's entering into the U.S. cannabinol market with the introduction of two new CBN isolate products.
Each bottle of Kannaway's newly released product contains 200 milligrams of CBD and 500 milligrams of CBG coming from European organic hemp.
Products are certified via the company's Triple Lab Testing process, the San Diego company confirmed.
"As CBD continues to grow in acceptance around the world, the market for cannabinoids like CBG also expands," noted Kannaway CEO Blake Schroeder. "Our company intends to continue to be at the forefront of expanding access to cannabinoids just as we have been with CBD."